Sucampo Acquires Vtesse Inc.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. COF
10. GOOGL

Go back to Sucampo Acquires Vtesse Inc.

Sucampo Pharmaceuticals (SCMP) PT Raised to $21 at Maxim Group; Vtesse 'Could Be a Great Deal'

April 3, 2017 3:20 PM EDT

Maxim Group raised its price target on Sucampo Pharmaceuticals (NASDAQ: SCMP) to $21.00 (from $19.00) while maintaining a Buy rating after the company acquired privately owned Vtesse Inc. and its lead orphan drug candidate for Niemann-Pick Type C1, VTS-270, for $200 million.

Analyst Jason... More